Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...

A study published in the journal Phytomedicine, conducted by researchers from the China-Japan Friendship Hospital, ...

Molecular Partners AG (OTCMKTS:MLLCF – Get Free Report)’s stock price dropped 9.4% on Monday . The stock traded as low as $4.53 and last traded at $4.53. Approximately 300 shares were traded during ...

Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...

Incyte (Nasdaq: INCY) today announced that the Company will present new data from across its oncology portfolio at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego. “These ...

Mitochondrial diseases, often stemming from complex genetic factors, impact the mitochondria's energy production. Japanese ...

Radiopharmaceutical company Telix Pharmaceuticals Ltd. has inked a deal worth up to AU$264 million (US$171 million) to license and develop next-generation radiopharma imaging and therapy technology ...

Cancer-associated fibroblast subtypes modulate the tumor immune microenvironment and are associated with the aggressiveness ...

This research provides a quantitative analysis of the fibroblast-to-myofibroblast transition (FMT), a critical process in ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update On Track to Initiate Phase 1/2 Trial in Diabetic Foot Ulcers FibroBiologics, Inc. (NASDAQ:FBLG) is on track to initiate a Phase 1/2 trial of ...

PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels ...

A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor environment. The results ...